Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Nov 16, 2023

SELL
$36.48 - $52.22 $11,053 - $15,822
-303 Closed
0 $0
Q3 2021

Nov 16, 2023

BUY
$50.07 - $66.05 $600 - $792
12 Added 4.12%
303 $15.2 Million
Q2 2021

Nov 16, 2023

BUY
$56.61 - $80.46 $2,773 - $3,942
49 Added 20.25%
291 $18.3 Million
Q1 2021

Nov 16, 2023

BUY
$86.23 - $125.19 $8,105 - $11,767
94 Added 63.51%
242 $22.5 Million
Q4 2020

Nov 16, 2023

BUY
$79.17 - $111.47 $11,717 - $16,497
148 New
148 $13.3 Million

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $623M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Disciplina Capital Management LLC Portfolio

Follow Disciplina Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Disciplina Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Disciplina Capital Management LLC with notifications on news.